ÂÜÀòÂÒÂ×

Chris joined Relievant in February 2018 and serves as Chief Financial Officer. Chris brings extensive experience from successful public and private companies and significant transaction experience. Prior to joining Relievant, he served as Chief Financial Officer of NeuWave Medical. After NeuWave’s acquisition by Johnson & Johnson in 2016, he continued on with J&J as a leader in the interventional oncology platform. Prior to NeuWave, Mr. Geyen served as CFO of Celleration where he guided the business through the process of securing reimbursement and acquisition by Alliqua BioMedical. He also served as CFO of Restore Medical (acquired by Medtronic), Acorn Cardiovascular, and Urologix.

Mr. Geyen holds a Bachelor of Arts in Business Administration and Accounting from the University of St. Thomas, Minnesota and is a licensed Certified Public Accountant (inactive). Chris serves as an independent board member at Preceptis Medical.